Softbank-backed Roivant to invest in hepatitis-B drug specialist via @FT
https://t.co/ipiF1iLqM0— The Propell Group (@ThePropellGroup) October 3, 2017
#healthtech
Softbank-backed Roivant to invest in hepatitis-B drug specialist via @FT
https://t.co/ipiF1iLqM0— The Propell Group (@ThePropellGroup) October 3, 2017
#healthtech